Management of Paroxystic Atrial Fibrillation in French Intensive Care Units
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 5, 2019
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Atrial fibrillation (AF) is a common arrhythmia in the ICU and is associated with significant morbidity. However, curative treatment remains unclearly established. In fact, there are no specific recommendations for new onset atrial fibrillation in ICU and only few studies have assessed this topic.
The PAF-ICU trial is an observational, prospective, multicenter, transversal trial. The main objective is to evaluate the management of paroxytic atrial fibrillation that occur in ICU.
The investigators want to document 2500 episodes of paroxystic atrial fibrillation in 50 ICU centers. In each c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Patient hospitalized in ICU
- • New onset atrial fibrillation
- Exclusion Criteria:
- • Age \< 18 years
- • Parturient or breast-feeding woman
- • Persistent or permanent atrial fibrillation
- • Patients after cardiovascular or thoracic surgery
- • Patients with therapeutic limitations
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Angers, , France
Grenoble, , France
Nice, , France
Toulouse, , France
Dijon, , France
Nancy, , France
Lille, , France
Clermont Ferrand, , France
Amiens, , France
Nîmes, , France
Paris, , France
Paris, , France
Besançon, , France
Cholet, , France
Dax, , France
Saint Etienne, , France
Marseille, , France
Rennes, , France
Nantes, , France
Montpellier, , France
Paris, , France
Marseille, , France
Lorient, , France
Paris, , France
Paris, , France
Argenteuil, , France
Bordeau, , France
Bourgoin Jallieu, , France
Brest, , France
Eaubonne, , France
Marseille, , France
Nice, , France
Patients applied
Trial Officials
Jean-Michel Constantin
Study Director
Réa Adulte CHU Clermont-Ferrand
Bernard Cosserant
Principal Investigator
Neuro-Réa CHU Clermont-Ferrand
Raiko Blondonnet
Principal Investigator
RMC CHU Clermont-Ferrand
Eric Kipnis
Principal Investigator
CHU Lille
Jonathan Paillot
Principal Investigator
CHU Besancçon
Charles Vidal
Principal Investigator
CHU de la Réunion
Laurent Muller
Principal Investigator
CHU Nimes
Johann Auchabie
Principal Investigator
CH Cholet
Guillaume Grillet
Principal Investigator
CH Lorient
Philippe Seguin
Principal Investigator
CHU Rennes
Philippe Guerci
Principal Investigator
CHRU Nancy
Bernard Lalanne
Principal Investigator
Hôpital Saint-Joseph - Marseille
Marc Leone
Principal Investigator
Hôpital Nord - APHM
Stanislas Ledochowski
Principal Investigator
CH Bourgoin-Jallieu
Matthieu Legrand
Principal Investigator
Hôpital Saint-Louis - APHP
Jeremy Bourenne
Principal Investigator
La Timone APHM
Michel Durand
Principal Investigator
University Hospital, Grenoble
Antoine Monsel
Principal Investigator
La Pitié Sapêtrière
Mathieu Guilbart
Principal Investigator
CHU Amiens
Matthieu Biais
Principal Investigator
University Hospital, Bordeaux
Cédric Bruel
Principal Investigator
CH Saint-Joseph Paris
Antoine Roquilly
Principal Investigator
Nantes University Hospital
Gaëtan Plantefeve
Principal Investigator
CH Argenteuil
Jérôme Morel
Principal Investigator
CHU SAINT-ETIENNE
Carole Ichai
Principal Investigator
CHU NICE
Adrien Auvet
Principal Investigator
CH Dax
Enora Atchade
Principal Investigator
Hôpital Bichat
Sigismond Lasocki
Principal Investigator
University Hospital, Angers
Pierre-Eric Danin
Principal Investigator
Clinique Les Sources Nice
Marc Danguy Des Deserts
Principal Investigator
Hôpital d'Instruction des Armées de Brest
Evelina Ochin Salatova
Principal Investigator
Hôpital Simone Veil - CH d'Eaubonne
Antoine Rouget
Principal Investigator
CHU Toulouse
Armand Mekontso Dessap
Principal Investigator
Hôpital Henri Mondor APHP
Justine Perrot
Principal Investigator
CHU Dijon
Jibba Amraoui
Principal Investigator
Institut Régional du Cancer de Montpellier
Matthias Garot
Principal Investigator
CHU Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials